Bupropion-Naltrexone (Contrave) for Weight Loss | Harbor

If you're considering bupropion-naltrexone for weight management, you probably want to understand the practical realities: how the drug works in your brain, what the first few weeks feel like, whether the weight-loss numbers hold up under scrutiny, and how it compares to the GLP-1 medications dominating headlines. This guide synthesizes the clinical evidence with the practical knowledge you need to make an informed decision.

The Two-Pathway Mechanism Behind Bupropion-Naltrexone

Bupropion is a dopamine and norepinephrine reuptake inhibitor originally developed as an antidepressant (Wellbutrin) and smoking cessation aid (Zyban). In the context of weight management, its primary action occurs in the hypothalamus, where it stimulates a group of neurons called pro-opiomelanocortin (POMC) neurons. When these neurons fire, they release alpha-melanocyte-stimulating hormone (α-MSH), which signals the body to reduce food intake and increase energy expenditure.

POMC neurons have a built-in feedback loop. When they fire, they also release beta-endorphin, an opioid peptide that acts in a feedback loop to dampen those same neurons. It's the brain's way of keeping appetite suppression in check. On its own, bupropion can kick-start POMC activity, but that endorphin feedback loop limits how much weight loss it can produce.

Naltrexone is an opioid receptor antagonist. It blocks the opioid receptors that beta-endorphin binds to. By doing so, naltrexone effectively removes the brake on POMC neuron firing. Bupropion presses the accelerator on appetite-suppressing neurons, and naltrexone prevents the brain from pumping the brakes. This one-two action also extends to the mesolimbic dopamine circuit, the reward pathway responsible for food cravings. Bupropion modulates dopamine signaling in this circuit, while naltrexone blunts the opioid-driven reinforcement that makes high-calorie foods feel rewarding. For people who struggle less with physical hunger and more with compulsive eating or cravings, this dual targeting of both appetite and reward is particularly relevant.

What the Clinical Evidence Actually Shows

Findings from clinical studies regarding the effectiveness and outcomes of using bupropion-naltrexone in weight management. The approval of bupropion-naltrexone rested on the Contrave Obesity Research (COR) trial program. Four large-scale, randomized, double-blind, placebo-controlled Phase 3 trials enrolling over 4,536 patients across 56 weeks.

Weight loss medicine results celebrated by a smiling young woman in a green sports bra pulling out the oversized waistband of her now-too-large jeans at home

Headline Numbers from the COR Trials

Across the trial program, patients taking bupropion-naltrexone at full dose (32 mg naltrexone / 360 mg bupropion daily) achieved an average weight loss of approximately 6.4–6.5% of baseline body weight, compared to 1.2–1.9% in the placebo group. That translates to a placebo-subtracted weight loss of roughly 4.2–5.2%, depending on the trial.

The proportion of patients achieving clinically meaningful thresholds tells a more nuanced story. In the COR-II trial, significantly more patients on bupropion-naltrexone reached the 5% weight-loss mark than placebo at both 28 and 56 weeks. Across trials, approximately 66% of treated patients lost at least 5% of their body weight, and around 42% lost 10% or more.

The Behavioral Modification Factor

The COR-BMOD trial added intensive behavioral modification to both the drug and placebo groups. Results were striking. The combination therapy group lost an average of 9.3% of body weight at 56 weeks, compared to 5.1% in the placebo-plus-behavior-modification group. This finding underscores a critical point: bupropion-naltrexone works best not as a standalone solution but as a tool layered on top of meaningful lifestyle changes.

Long-Term Maintenance Data

A key concern with any weight loss medication is whether the results stick. One research examined longer-term outcomes and found that bupropion-naltrexone promotes weight loss that can be maintained for up to four years in most patients who continue therapy. Early response, defined as losing at least 5% of body weight by week 16, is the strongest predictor of sustained results. Beyond weight, the COR trials also showed statistically significant improvements in waist circumference, triglycerides, HDL cholesterol, fasting insulin, insulin resistance, and obesity-specific quality of life compared to placebo.

Your First 12 Weeks: A Realistic Timeline

The Dose Escalation Schedule

Each bupropion-naltrexone tablet contains 8 mg naltrexone and 90 mg bupropion. You don't start at full dose. Instead, the medication follows a four-week titration:

Week 1: One tablet in the morning
Week 2: One tablet in the morning, one in the evening
Week 3: Two tablets in the morning, one in the evening
Week 4 and beyond: Two tablets in the morning, two in the evening (full dose: 32 mg naltrexone / 360 mg bupropion daily)

This ramp-up exists for a reason. Jumping straight to full dose dramatically increases the likelihood and severity of side effects, particularly nausea.

Nausea and Other Early Side Effects

Nausea is the most common side effect, affecting roughly one in three patients during the early weeks of treatment. It's also the leading reason people discontinue the medication before giving it a fair chance. Constipation affects approximately 19% of patients, followed by headache, dizziness, insomnia, dry mouth, and vomiting at lower rates. The important context is that these effects are front-loaded. They peak during the titration phase and typically diminish substantially as your body adjusts. Practical strategies that clinicians recommend include taking tablets with food and keeping meals smaller and more frequent during the first few weeks.

The 12-Week Checkpoint

If you haven't lost at least 5% of your starting body weight by week 12, discontinue therapy. At that point, continued use is unlikely to produce clinically meaningful results. This is a pharmacological reality. Some people's neurobiology simply responds less to this particular mechanism. In the COR trials, approximately 46% of patients on bupropion-naltrexone had achieved ≥5% weight loss by week 16. This built-in checkpoint gives both you and your doctor an objective measure of whether the medication is working for your body.

Medical weight loss target area shown as a woman in a white crop top pinching abdominal fat against a light gray background

Who Should, and Shouldn't, Consider This Medication

The FDA-Approved Criteria

The approved indications specify adults with a BMI of 30 kg/m² or greater (obesity), or a BMI of 27 kg/m² or greater (overweight) with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidemia. It's prescribed as an adjunct to a reduced-calorie diet and increased physical activity, not as a replacement for lifestyle changes. The recommended lifestyle changes, such as diet and exercise, and the role of support programs, enhance the effectiveness of bupropion-naltrexone.

Beyond BMI: Who Benefits Most

The clinical data and the drug's mechanism suggest certain patient profiles may respond particularly well. People whose weight challenges center on food cravings, emotional eating, or reward-driven eating patterns may find the dual action on both appetite and reward circuits especially helpful. Similarly, patients who already have some behavioral modification framework in place, whether through a structured program, nutritional counseling, or a platform like Harbor that provides guided support for weight management, tend to see stronger results, consistent with the COR-BMOD trial findings. Patients who need a mood boost alongside weight management may also benefit, since bupropion's antidepressant properties can address the low mood and fatigue that sometimes accompany calorie restriction.

Medication Interactions and Precautions

Before beginning bupropion-naltrexone (Contrave), it’s essential to understand how this medication may interact with other drugs and what precautions are necessary to ensure safe and effective use. Bupropion-naltrexone has several known interactions that can significantly impact your health if not properly managed. One of the most critical interactions involves opioids; because naltrexone is an opioid receptor antagonist, taking it while using opioid pain medications (such as codeine, oxycodone, morphine, or methadone) can precipitate sudden and severe withdrawal symptoms. For this reason, you must be opioid-free for at least 7 to 10 days before starting treatment. Similarly, it should not be combined with medications used for opioid dependence or withdrawal, as this can also lead to dangerous reactions.

Another major interaction is with monoamine oxidase inhibitors (MAOIs), a class of antidepressants. Taking bupropion-naltrexone within 14 days of using an MAOI can cause serious, potentially life-threatening side effects, including high blood pressure and seizures. Additionally, you should not take it alongside other medications that contain bupropion (such as Wellbutrin or Zyban), as this increases the risk of seizures. Other medications that may raise seizure risk when combined with bupropion-naltrexone include certain antipsychotics, antidepressants, corticosteroids, and drugs for Parkinson’s disease (like levodopa and amantadine). Alcohol consumption, abrupt discontinuation of alcohol, or stopping sedatives or benzodiazepines suddenly can further elevate this risk.

Blood thinners (such as warfarin or clopidogrel), certain diabetes medications (especially insulin or sulfonylureas), and some herbal supplements may also interact with bupropion-naltrexone, potentially altering drug effectiveness or increasing side effects. Always provide your healthcare provider with a comprehensive list of all prescription and over-the-counter medications, vitamins, and supplements you are taking.

Precautions before starting bupropion-naltrexone go beyond medication interactions. This treatment is contraindicated in people with a history of seizures, eating disorders (anorexia or bulimia), uncontrolled high blood pressure, or severe liver or kidney disease. It is also not recommended for those who are pregnant, breastfeeding, or under 18 years old. Individuals with mental health conditions, such as depression or a history of suicidal thoughts, should be especially cautious, as bupropion carries a boxed warning for increased risk of suicidal ideation, particularly in young adults. Regular monitoring of blood pressure and mental health status is advised throughout treatment. Open and ongoing communication with your healthcare provider is crucial to managing risks and ensuring that bupropion-naltrexone is a safe, appropriate option for your weight management journey.

How Bupropion-Naltrexone Fits in the Current Weight Loss Medication Landscape

The Numbers Side by Side

A 2025 systematic review and meta-analysis contextualized the efficacy of available anti-obesity medications. GLP-1 receptor agonists like semaglutide produce an average weight loss of approximately 13.7% of body weight, while dual incretin agonists like tirzepatide can reach 15–21% depending on dose. Bupropion-naltrexone's 5–7% total-body weight loss places it in a lower-efficacy tier.

Insurance, Cost, and Access

If you’re considering bupropion-naltrexone (Contrave) for weight management, understanding the financial and logistical aspects is just as important as knowing how the medication works. Below are key considerations regarding insurance coverage, out-of-pocket costs, and how to access this medication.

Insurance Coverage and Out-of-Pocket Costs: Insurance coverage for bupropion-naltrexone varies widely. Some plans may cover the medication, while others do not, leaving patients to pay out of pocket. Typical monthly costs range from $99 to over $200, depending on pharmacy discounts and insurance status.
Clinic Memberships and Bundled Pricing: Certain clinics and telehealth platforms offer bundled memberships that include the cost of bupropion-naltrexone. These memberships often start at a lower introductory rate and increase after the initial period.
Access via Online Prescriptions and Eligibility: Many people now access bupropion-naltrexone through online healthcare providers, which may require a short medical assessment to determine eligibility. After approval, prescriptions can be filled at a local pharmacy or delivered directly, streamlining the process for those without easy access to in-person care.

Navigating insurance, understanding potential costs, and knowing your options for obtaining a prescription can help you make an informed decision about starting bupropion-naltrexone. Always review your insurance benefits and explore clinic or telehealth options to find the most accessible and affordable route.

Bupropion-naltrexone treatment progress shown as a woman in black leggings stepping barefoot onto a bathroom scale beside a coiled yellow tape measure on a wood floor

Practical Strategies for Getting the Most from Treatment

Don't wait for nausea to become unbearable before adjusting your approach. From day one, plan to take tablets with a moderate meal, avoid high-fat foods around dosing times, increase water intake, and keep portions smaller and more frequent. Some clinicians also allow a slightly slower titration for patients who are particularly sensitive to nausea, though this should be discussed with your prescriber. Weigh yourself under consistent conditions so you have reliable data at the 12-week mark. If you haven't reached the 5% threshold, that information is clinically useful. It means this particular medication isn't the right fit for your biology, and your physician can explore alternatives.

Bupropion carries a boxed warning about suicidal thoughts and behavior, particularly in young adults under 25. While this risk appears low in the weight management population, it's important to stay attuned to mood changes, increased irritability, agitation, or unusual behavior during the early weeks. Report any such changes to your prescriber promptly. On the positive side, many patients report improved mood and energy effects consistent with bupropion's antidepressant mechanism.

Bupropion-naltrexone can be a powerful component of a weight management strategy, but no medication operates in a vacuum. The data consistently show that pharmacotherapy produces the strongest, most durable results when it's embedded within a broader framework of nutritional change, physical activity, behavioral support, and ongoing medical monitoring.

The four-year maintenance data are encouraging, but it also raises an important question: What happens when the medication stops? Obesity is increasingly understood as a chronic, relapsing condition driven by neurobiological and metabolic factors that persist after weight loss. Medications like bupropion-naltrexone address some of those factors, but discontinuation often leads to weight regain. This reframing matters. Bupropion-naltrexone isn't a temporary fix to "get the weight off" before returning to baseline. For many patients, it's part of a long-term management plan, similar to how statins manage cholesterol or metformin manages blood sugar. Having that conversation with your physician early sets the foundation for realistic outcomes.

Frequently Asked Questions

What is bupropion-naltrexone (Contrave)?

Bupropion-naltrexone is a prescription medication that combines two drugs—bupropion and naltrexone—designed to help adults lose weight or maintain weight loss.

What is Contrave used for?Contrave is used as part of a comprehensive weight management plan for adults with obesity or those who are overweight and have weight-related health conditions.

How is Contrave different from other weight loss medications?Contrave is an oral pill that targets both appetite and cravings, making it distinct from other medications that may act differently or require injections.

Who is eligible to use Contrave?Adults with a body mass index (BMI) of 30 or higher, or 27 or higher with at least one weight-related health issue, may be considered for Contrave.

Is Contrave a replacement for diet and exercise?No, Contrave is intended to be used alongside a reduced-calorie diet and increased physical activity—not as a standalone solution.

The landscape of obesity pharmacotherapy is evolving rapidly, with new mechanisms, combination approaches, and treatment paradigms emerging every year. Within that landscape, bupropion-naltrexone occupies a specific and evidence-supported niche: an oral, accessible option that addresses both the appetite and reward dimensions of overeating, with meaningful efficacy for patients who pair it with genuine lifestyle change.

Sources: